| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a10dc651e733b8d5a1ec5684b812362 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a512148e4f106b04bc8090f360a7cc99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_620ffd6dff0ad4961b63ec6bff48119b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a57fdd900bece4b5bff0b1044993feee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c1cf8659afe7a092f150b8234901bbe |
| publicationDate |
2013-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201336508-A |
| titleOfInvention |
Immune method against four dengue serotypes |
| abstract |
The present invention relates to a method for inducing protection against four dengue serotypes in a patient, comprising: (a) a first series of administrations (i) a dose of the first serotype vaccine for dengue virus and one a second serotype vaccine for dengue virus; and (ii) a third serotype vaccine for dengue virus and a fourth serotype for dengue virus, and (b) a second series The agents (i) and (ii), wherein the (i) and (ii) agents are administered simultaneously at different anatomical sites, and wherein the second series is administered at least 30 days to at most 12 months after the first series . |
| priorityDate |
2006-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |